Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-030096
Filing Date
2024-12-23
Accepted
2024-12-23 17:36:13
Documents
1
Period of Report
2024-12-19

Document Format Files

Seq Description Document Type Size
1 form4-12232024_101210.html 4  
1 form4-12232024_101210.xml 4 4337
  Complete submission text file 0001415889-24-030096.txt   6033
Mailing Address 17383 SUNSET AVENUE SUITE A250 PACIFIC PALISADES CA 90272
Business Address 17383 SUNSET AVENUE SUITE A250 PACIFIC PALISADES CA 90272 424-473-8055
Aadi Bioscience, Inc. (Issuer) CIK: 0001422142 (see all company filings)

EIN.: 611547850 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O AADI BIOSCIENCE, INC. 17383 SUNSET AVENUE, SUITE A250 PACIFIC PALISADES CA 90272
Business Address
Zhao Baiteng (Reporting) CIK: 0002049287 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38560 | Film No.: 241575089